Thirteen patients mainly with lower respiratory tract infections were treated with ceftazidime (CAZ). The drug was given intravenously in a dose of 11 approximately 34 mg per 1 kg of body weight 2 approximately 3 times per day. The clinical response to treatment was satisfactory in 10 patients (76.9%). There was no side effects. CAZ appears to be an safe and effective antibiotic for the treatment of children with bacterial infections.